Eric Coldwell

Q: What is Eric Coldwell's success rate?

Eric Coldwell currently has a success rate of 90.02879522873928.

Q: What is the average return of Eric Coldwell's calls?

Their stock ratings have generated an average return of 21.59798339094687.

Baird | Healthcare

Eric Coldwell is an analyst from Baird specializing in the Healthcare sector. Ranked #1454 out of 4714 analysts, they have issued 24 stock ratings with a success rate of 90.03% and an average return of 21.60%.

Eric Coldwell has a well-established track record, with 24 ratings issued in the Healthcare sector. They have consistently delivered a success rate of 90.03% and an average return of 21.60%, underscoring their expertise and ability to identify winning opportunities for investors.

#1454

Out of 4714

Total Ratings

+90.03%

Success Rate

+21.60%

Average Return

Recent Ratings Analysis

MEDP

Hold

Jul 08, 2026

Target

$547.00

Current

$531.99

Performance

0.00%

Eric Coldwell rated MEDP as Neutral on Jul 08, 2026, setting a price target of 547. The Hold stance appears justified, as shares hovered around 531.99 with a 0.00% move.

AHCO

Buy

Jul 06, 2026

Target

$15.00

Current

$9.99

Performance

-2.73%

On Jul 06, 2026, AHCO was given a Outperform rating by Eric Coldwell, with a target price of 15. The stock traded sideways with a -2.73% move, keeping the bullish thesis unresolved.

IQV

Buy

Jul 01, 2026

Target

$249.00

Current

$203.79

Performance

0.29%

IQV received a Outperform rating from Eric Coldwell on Jul 01, 2026, aiming for 249. Price action was muted, as shares hovered around 203.79 despite the bullish outlook.

ICLR

Buy

Jun 25, 2026

Target

$186.00

Current

$165.47

Performance

2.80%

On Jun 25, 2026, Eric Coldwell published a Outperform outlook on ICLR, with a target of 186. So far, the stock has neither confirmed nor rejected the Buy case, holding within range of 165.47.

MDLN

Buy

Jun 03, 2026

Target

$45.00

Current

$40.30

Performance

16.91%

Eric Coldwell on Jun 03, 2026 assigned MDLN a Outperform rating, with a price target of 45. The Buy call aligned well with market performance, producing a gain of 16.91%.

ACH

Buy

May 12, 2026

Target

$6.00

Current

$3.17

Performance

-0.94%

On May 12, 2026, Eric Coldwell reaffirmed ACH with a Outperform rating, targeting 6. Market indecision has kept the 6 target in a holding pattern.

DGX

Hold

Apr 22, 2026

Target

$229.00

Current

$208.21

Performance

2.06%

DGX was rated Neutral by Eric Coldwell on Apr 22, 2026, with a price objective of 229. Flat performance suggests the Hold view was reasonable.

FTRE

Buy

Feb 27, 2026

Target

$19.00

Current

$17.02

Performance

58.77%

On Feb 27, 2026, Eric Coldwell initiated coverage on FTRE with a Outperform rating and target of 19. The stock’s climb of 58.77% since the call highlights the foresight in the rating.

LH

Buy

Feb 18, 2026

Target

$326.00

Current

$277.74

Performance

-0.37%

Eric Coldwell issued a Outperform recommendation for LH on Feb 18, 2026, price target set at 326. The target of 326 remains in play, though confirmation will depend on future moves.

MCK

Buy

Nov 06, 2025

Target

$927.00

Current

$818.66

Performance

-4.65%

On Nov 06, 2025, MCK was evaluated by Eric Coldwell, who gave a Outperform rating and target of 927. So far, the Buy call awaits clearer momentum, with shares flat at 818.66.

CRL

Buy

Nov 06, 2025

Target

$199.00

Current

$223.96

Performance

31.06%

Eric Coldwell rated CRL as Outperform on Nov 06, 2025, setting a price target of 199. The call has proven timely, with shares rising 31.06% toward the price target of 199.

PINC

Hold

Aug 20, 2025

Target

$27.00

Current

$50.01

Performance

95.75%

On Aug 20, 2025, PINC was given a Neutral rating by Eric Coldwell, with a target price of 27. The stock rallied from 50.0149 to 50.0149 after the Hold rating, surprising to the upside.

CAH

Buy

Aug 13, 2025

Target

$203.00

Current

$237.15

Performance

60.11%

CAH received a Outperform rating from Eric Coldwell on Aug 13, 2025, aiming for 203. Momentum has favored the Buy call, with shares climbing from 237.15 to 237.15, rewarding those who trusted the recommendation.

OMI

Buy

Aug 12, 2025

Target

$7.00

Current

$2.68

Performance

-51.01%

On Aug 12, 2025, Eric Coldwell published a Outperform outlook on OMI, with a target of 7. Market action contradicted the Buy thesis, as shares slipped to 2.68.

CTLT

Hold

Sep 24, 2024

Target

$63.50

Current

$63.48

Performance

5.55%

Eric Coldwell on Sep 24, 2024 assigned CTLT a Neutral rating, with a price target of 63.5. Shares outperformed expectations, climbing 5.55% despite the neutral view.

Frequency Asked Questions

Who is Eric Coldwell?

Eric Coldwell is an analyst from Baird specializing in the Healthcare sector.

What is Eric Coldwell's success rate?

Eric Coldwell currently has a success rate of +90.03%.

How many ratings has Eric Coldwell issued?

Eric Coldwell has issued 24 stock ratings so far.

What is the average return of Eric Coldwell's calls?

Their stock ratings have generated an average return of +21.60%.

What is Eric Coldwell's ranking?

Eric Coldwell is ranked #1454 out of 4714 analysts.

What types of ratings does Eric Coldwell give?

Their ratings include Buy, Hold, and Sell recommendations, depending on the stock’s outlook.

How can I follow Eric Coldwell?

You can follow Eric Coldwell by clicking the "Follow Analyst" button on this page to receive updates on their stock calls.

What is the most recent rating by Eric Coldwell?

Their latest rating was a Hold on MEDP issued on 2026-07-08.